Cargando…
Impact of recent FDA ruling on testosterone replacement therapy (TRT)
Autores principales: | Metzger, Sarita O., Burnett, Arthur L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182241/ https://www.ncbi.nlm.nih.gov/pubmed/28078224 http://dx.doi.org/10.21037/tau.2016.09.08 |
Ejemplares similares
-
AB004. Contemporary perspectives on testosterone replacement therapy (TRT)
por: Hellstrom, Wayne J. G.
Publicado: (2015) -
Development of a men’s Preference for Testosterone Replacement Therapy (P-TRT) instrument
por: Szeinbach, Sheryl L, et al.
Publicado: (2012) -
AB04. Novel approaches for testosterone replacement therapy
por: Burnett, Arthur L. (Bud)
Publicado: (2014) -
Understanding and managing the suppression of spermatogenesis caused
by testosterone replacement therapy (TRT) and anabolic–androgenic steroids
(AAS)
por: Desai, Ankit, et al.
Publicado: (2022) -
SUN-223 Impact of Testosterone Replacement Therapy (TRT) on Prostate Specific Antigen (PSA) in Patients with Clinical Evidence of Prostate Hyperplasia
por: Subramaniam, Shreya, et al.
Publicado: (2019)